Structure of the Saccharolobus solfataricus type III-D CRISPR effector

Athukoralage, 2022, Cyclic nucleotide signaling in phage defense and counter-defense, Ann. Rev. Virol., 9, 451, 10.1146/annurev-virology-100120-010228 Benda, 2014, Structural model of a CRISPR RNA-silencing complex reveals the RNA-target cleavage activity in Cmr4, Mol. Cell, 56, 43, 10.1016/j.molcel.2014.09.002 Bokori-Brown, 2016, Cryo-EM structure of lysenin pore elucidates membrane insertion by an aerolysin family protein, Nat. Commun., 7, 10.1038/ncomms11293 Brouns, 2008, Small CRISPR RNAs guide antiviral defense in prokaryotes, Science, 321, 960, 10.1126/science.1159689 Casanal, 2020, Current developments in Coot for macromolecular model building of electron cryo-microscopy and crystallographic data, Protein Sci., 29, 1069, 10.1002/pro.3791 Charbonneau, 2021, Cyclic tetra-adenylate (cA4) recognition by Csa3; implications for an integrated class 1 CRISPR-cas immune response in Saccharolobus solfataricus, Biomolecules, 11, 10.3390/biom11121852 Danev, 2014, Volta potential phase plate for in-focus phase contrast transmission electron microscopy, Proc Natl Acad Sci U S A, 111, 15635, 10.1073/pnas.1418377111 Grüschow, 2021, Specificity and sensitivity of an RNA targeting type III CRISPR complex coupled with a NucC endonuclease effector, Nucl. Acids Res., gkab119., 10.1093/nar/gkab1190 Guo, 2019, Coupling of ssRNA cleavage with DNase activity in type III-A CRISPR-Csm revealed by cryo-EM and biochemistry, Cell Res., 29, 305, 10.1038/s41422-019-0151-x Hale, 2009, RNA-guided RNA cleavage by a CRISPR RNA-Cas protein complex, Cell, 139, 945, 10.1016/j.cell.2009.07.040 Hale, 2014, Target RNA capture and cleavage by the Cmr type III-B CRISPR-Cas effector complex, Genes & Development, 28, 2432, 10.1101/gad.250712.114 Jia, 2019, Type III-A CRISPR-cas Csm complexes: assembly, periodic RNA cleavage, DNase activity regulation, and autoimmunity, Mol. Cell, 73, 264, 10.1016/j.molcel.2018.11.007 Johnson, 2019, -Target sequence requirements of a type III-B CRISPR-Cas immune system, J. Biol. Chem., 294, 10290, 10.1074/jbc.RA119.008728 Jumper, 2021, Highly accurate protein structure prediction with AlphaFold, Nature, 596, 583, 10.1038/s41586-021-03819-2 Kazlauskiene, 2016, Spatiotemporal control of type III-A CRISPR-cas immunity: coupling DNA degradation with the target RNA recognition, Mol. Cell, 62, 295, 10.1016/j.molcel.2016.03.024 Kazlauskiene, 2017, A cyclic oligonucleotide signaling pathway in type III CRISPR-Cas systems, Science, 357, 605, 10.1126/science.aao0100 Lau, 2020, Structure and mechanism of a cyclic trinucleotide-activated bacterial endonuclease mediating bacteriophage immunity, Mol. Cell, 77, 723, 10.1016/j.molcel.2019.12.010 Liebschner, 2019, Macromolecular structure determination using X-rays, neutrons and electrons: recent developments in Phenix, Acta Crystallogr. D Struct. Biol., 75, 861, 10.1107/S2059798319011471 Liu, 2019, Target preference of Type III-A CRISPR-Cas complexes at the transcription bubble, Nat. Commun., 10, 3001, 10.1038/s41467-019-10780-2 Makarova, 2015, An updated evolutionary classification of CRISPR-Cas systems, Nat. Rev. Microbiol., 13, 722, 10.1038/nrmicro3569 Makarova, 2020, Evolutionary classification of CRISPR-Cas systems: a burst of class 2 and derived variants, Nat. Rev. Microbiol., 18, 67, 10.1038/s41579-019-0299-x Mariani, 2013, lDDT: a local superposition-free score for comparing protein structures and models using distance difference tests, Bioinformatics, 29, 2722, 10.1093/bioinformatics/btt473 McMahon, 2020, Structure and mechanism of a Type III CRISPR defence DNA nuclease activated by cyclic oligoadenylate, Nat. Commun., 11, 500, 10.1038/s41467-019-14222-x Mirdita, 2022, ColabFold: making protein folding accessible to all, Nat. Methods, 19, 679, 10.1038/s41592-022-01488-1 Niewoehner, 2017, Type III CRISPR-Cas systems produce cyclic oligoadenylate second messengers, Nature, 548, 543, 10.1038/nature23467 Pantelic, 2010, Graphene oxide: a substrate for optimizing preparations of frozen-hydrated samples, J. Struct. Biol., 170, 152, 10.1016/j.jsb.2009.12.020 Pettersen, 2021, UCSF ChimeraX: structure visualization for researchers, educators, and developers, Protein Sci., 30, 70, 10.1002/pro.3943 Rostol, 2019, Non-specific degradation of transcripts promotes plasmid clearance during type III-A CRISPR-Cas immunity, Nat. Microbiol., 4, 656, 10.1038/s41564-018-0353-x Rostol, 2021, The Card1 nuclease provides defence during type-III CRISPR immunity, Nature, 590, 614, 10.1038/s41586-021-03206-x Rouillon, 2013, Structure of the CRISPR interference complex Csm reveals key similarities with cascade, Mol. Cell, 52, 124, 10.1016/j.molcel.2013.08.020 Rouillon, 2018, Control of cyclic oligoadenylate synthesis in a type III CRISPR system, Elife, 7, 10.7554/eLife.36734 Santiago-Frangos, 2021, Intrinsic signal amplification by type III CRISPR-Cas systems provides a sequence-specific SARS-CoV-2 diagnostic, Cell Rep Med, 2 Smith, 2022, Structures of an active type III-A CRISPR effector complex, Structure, 30, 1109, 10.1016/j.str.2022.05.013 Sofos, 2020, Structures of the cmr-beta complex reveal the regulation of the immunity mechanism of type III-B CRISPR-cas, Mol. Cell, 79, 741, 10.1016/j.molcel.2020.07.008 Sokolowski, 2014, Cas6 specificity and CRISPR RNA loading in a complex CRISPR-Cas system, Nucleic Acids Res., 42, 6532, 10.1093/nar/gku308 Spilman, 2013, Structure of an RNA silencing complex of the CRISPR-cas immune system, Mol. Cell, 52, 146, 10.1016/j.molcel.2013.09.008 Staals, 2013, Structure and activity of the RNA-targeting Type III-B CRISPR-Cas complex of Thermus thermophilus, Mol. Cell, 52, 135, 10.1016/j.molcel.2013.09.013 Staals, 2014, RNA targeting by the type III-A CRISPR-Cas Csm complex of Thermus thermophilus, Mol. Cell, 56, 518, 10.1016/j.molcel.2014.10.005 Steens, 2021, SCOPE enables type III CRISPR-Cas diagnostics using flexible targeting and stringent CARF ribonuclease activation, Nat. Commun., 12, 5033, 10.1038/s41467-021-25337-5 Tamulaitis, 2014, Programmable RNA shredding by the type III-A CRISPR-Cas system of Streptococcus thermophilus, Mol. Cell, 56, 506, 10.1016/j.molcel.2014.09.027 Tamulaitis, 2017, Type III CRISPR-cas immunity: major differences brushed aside, Trends Microbiol., 25, 49, 10.1016/j.tim.2016.09.012 Wang, 2019, Dynamics of Cas10 govern discrimination between self and non-self in type III CRISPR-cas immunity, Mol. Cell, 73, 278, 10.1016/j.molcel.2018.11.008 Yamashita, 2021, Cryo-EM single-particle structure refinement and map calculation using Servalcat, Acta Crystallogr. D Struct. Biol., 77, 1282, 10.1107/S2059798321009475 You, 2019, Structure studies of the CRISPR-csm complex reveal mechanism of Co-transcriptional interference, Cell, 176, 239, 10.1016/j.cell.2018.10.052 Zhang, 2012, Structure and mechanism of the CMR complex for CRISPR-mediated antiviral immunity, Mol. Cell, 45, 303, 10.1016/j.molcel.2011.12.013 Zhang, 2012, Structure and mechanism of the CMR complex for CRISPR-mediated antiviral immunity, Mol. Cell, 45, 303, 10.1016/j.molcel.2011.12.013 Zhang, 2016, Multiple nucleic acid cleavage modes in divergent type III CRISPR systems, Nucleic Acids Res., 44, 1789, 10.1093/nar/gkw020 Zhu, 2021, The CRISPR ancillary effector Can2 is a dual-specificity nuclease potentiating type III CRISPR defence, Nucleic Acids Res., 49, 2777, 10.1093/nar/gkab073 Zivanov, 2018, New tools for automated high-resolution cryo-EM structure determination in RELION-3, Elife, 7, 10.7554/eLife.42166